Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
PZ HTL SA

Omega-3 Fatty Acid Derivative Slows Tumor Growth by Blocking Formation of New Blood Vessels

By BiotechDaily International staff writers
Posted on 18 Apr 2013
A metabolite derived from an omega-3 fatty acid slows tumor growth by blocking the development of new blood vessels (angiogenesis).

Investigators at the University of California, Davis (USA) worked with cancer cell cultures and mouse cancer models to examine the effects of omega-3 and omega-6 fatty acids on tumor growth.

They reported in the April 3, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that epoxy docosapentaenoic acid (EDP), a compound produced by the human body from the fish oil omega-3 fatty acid docosahexaenoic acid (DHA), inhibited primary tumor growth and metastasis by up to nearly 70%. The blocking of tumor growth was shown in a mouse cancer model to be due to EDP-mediated inhibition of vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2)-induced angiogenesis. In cancer cell cultures, EDP also suppressed the endothelial cell migration needed for new blood vessels.

In contrast, epoxyeicosatrienoic acids (EETs), metabolites of the omega-6 fatty acid arachidonic acid (ARA), slightly increased angiogenesis and tumor progression in mice.

“EDP works by a different mechanism than many current anticancer drugs that block angiogenesis,” said first author Dr. Guodong Zhang, a postdoctoral cancer researcher at the University of California, Davis. “Our investigation opens up a new understanding of the pathways by which omega-3 fatty acids exert their biologic effects. As far as we know, EDPs are the first signaling lipids that have been discovered to have such potent anticancer effects. Researchers may be able to use EDPs as structural targets to develop stable analogs as anticancer agents.”

Related Links:
University of California, Davis



Channels

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.